Therapies for Preexisting Cardiovascular Disease (Patient Taking Prior to Admission) Terminology

Preferred Label : Therapies for Preexisting Cardiovascular Disease (Patient Taking Prior to Admission) Terminology;

NCIt related terms : Therapies for Preexisting Cardiovascular Disease (Patient Taking Prior to Admission);

NCIt definition : Terminology from the American College of Cardiology (ACC)/American Heart Association (AHA) describing the therapies taken for pre-existing cardiovascular disease prior to COVID-19 infection (from 2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. Bozkurt B et al. Circ Cardiovasc Qual Outcomes. 2022; 15:e000111).;

NCI Metathesaurus CUI : CL1905107;

Détails

Origin ID

C191405;

UMLS CUI

C5784455;

Semantic type(s)
- Intellectual Product [UMLS semantic type]
concept_is_in_subset
- Appendix 8: Pharmacological Therapy Terminology [NCIt concept]
subset_includes_concept
- ACE Inhibitor [NCIt concept]
- Aldosterone Receptor Antagonist [NCIt concept]
- Angiotensin II Receptor Antagonist [NCIt concept]
- Angiotensin Receptor-Neprilysin Inhibitor [NCIt concept]
- Aspirin [NCIt concept]
- Bempedoic Acid [NCIt concept]
- Beta-Adrenergic Antagonist [NCIt concept]
- Direct Oral Anticoagulant [NCIt concept]
- Ezetimibe [NCIt concept]
- GLP-1 Mimetics [NCIt concept]
- HMG-CoA Reductase Inhibitor [NCIt concept]
- Metformin [NCIt concept]
- P2Y12 Inhibitor [NCIt concept]
- PCSK9 Inhibitor [NCIt concept]
- Preexisting Cardiovascular Disease Therapy [NCIt concept]
- SGLT2 Inhibitor [NCIt concept]
- Unknown [NCIt concept]
- Warfarin [NCIt concept]
- Yes [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients